Jorge Gonzalez never got the chance to make his UFC debut and now it appears he’ll have to wait until at least 2022 for that opportunity.
On Friday, United States Anti-Doping Agency officials announced Gonzalez tested positive for multiple banned substances and he’s now been suspended two years under the UFC’s anti-doping policy.
“Gonzalez Villa, 36, tested positive for stanozolol metabolites 16β-hydroxystanozolol and 4β-hydroxystanozolol, drostanolone metabolite 2α-methyl-5α-androstan-3α-ol-17-one, and tamoxifen metabolite 3-hydroxy-4-methoxytamoxifen as the result of a urine sample collected out-of-competition on August 5, 2020,” USADA officials wrote.
“Upon being added to the UFC Anti-Doping Program, athletes are required to declare all medications and supplements they have used in the previous 12 months. An athlete who declares the prior use of a prohibited substance will not be deemed to have committed a violation but, depending on the substance, may be required to refrain from competition for a period of at least six months and provide at least two negative samples. Gonzalez Villa did not declare the use of stanozolol, drostanolone, or tamoxifen on his onboarding declaration forms.”
Stanozolol and drostanolone are both anabolic steroids while tamoxifen is actually a breast cancer drug. As a performance-enhancing substance, tamoxifen is typically used to counteract the side effects commonly seen when using steroids.
Initially, Gonzalez was scheduled to fight on Aug. 22 against Ike Villanueva but he was pulled from the card due after his drug test was flagged. He also had a fight originally scheduled in July but that bout was scrapped after Gonzalez’s opponent missed weight.
Because Gonzalez didn’t disclosed prior drug use when signing with the UFC, he faced the maximum penalty, which resulted in a two-year suspension from the sport. He won’t be eligible to compete again until after Aug. 5, 2022.